Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15.
Published January 24, 2018 · Recall initiated: January 3, 2018
Summary
FDA records drug Class II recall D-0222-2018, published January 24, 2018 and initiated January 3, 2018. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 237 cartons; Lot: Lot: 15270, Exp. 01/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AVKARE Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot: 15270, Exp. 01/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDAPhytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478.June 23, 2021
- FDATraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TNDecember 23, 2020
- FDASildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDCDecember 23, 2020
- FDAPhenylephrine HCL 100 mcg per mL (1 mg/10 mL) in 0.9% Sodium Chloride 10 mL syringes, PharMEDium Services, LLCJanuary 24, 2018
- FDARugby Diocto Liquid, Docusate Sodium 50 mg/ 5 mL, Stool Softener Laxative, One Pint (473 mL) plastic bottles,January 24, 2018
Questions about this recall
Was Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15. recalled?
Yes. FDA published recall D-0222-2018 on January 24, 2018. Reported hazard: Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter